A Trojan Horse in Drug Development: Targeting of Thapsigargins Towards Prostate Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|9|3|276-294

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.9, Iss.3, 2009-01, pp. : 276-294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Prostate Cancer Stem Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1105-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Functional characteristics of cancer stem cells and their role in drug resistance of prostate cancer

By          

International Journal of Oncology, Vol. 45, Iss. 3, 2014-01 ,pp. : 985-994

Spandidos Publications

Access to resources Recommend Favorite

microRNA-133 inhibits cell proliferation, migration and invasion in prostate cancer cells by targeting the epidermal growth factor receptor

By                

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1967-1975

Spandidos Publications

Access to resources Recommend Favorite

microRNA155 promotes the proliferation of prostate cancer cells by targeting annexin 7

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 533-538

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of microRNA-429 inhibits cell proliferation by targeting p27Kip1 in human prostate cancer cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1435-1441

Spandidos Publications

Access to resources Recommend Favorite